Experimental study of 131I-caerin 1.1 and 131I-c(RGD)2 for internal radiation therapy of esophageal cancer xenografts

MLA

Tiantian He, et al. “Experimental Study of 131I-Caerin 1.1 and 131I-c(RGD)2 for Internal Radiation Therapy of Esophageal Cancer Xenografts.” Biomedicine & Pharmacotherapy, vol. 164, Aug. 2023, p. 114891. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.114891.

APA

Tiantian He, Juan Du, Keke Zhu, Yixuan Zhou, Zewei Xiao, Wenjie Liu, Weiwei Ren, Xiongying Liu, Tongsheng Chen, Wenjuan Liu, Zhuanming Chen, Guoying Ni, Xiaosong Liu, Tianfang Wang, Jiangtao Quan, Peipei Zhang, & Jianwei Yuan. (2023). Experimental study of 131I-caerin 1.1 and 131I-c(RGD)2 for internal radiation therapy of esophageal cancer xenografts. Biomedicine & Pharmacotherapy, 164, 114891. https://doi.org/10.1016/j.biopha.2023.114891

Chicago

Tiantian He, Juan Du, Keke Zhu, Yixuan Zhou, Zewei Xiao, Wenjie Liu, Weiwei Ren, et al. 2023. “Experimental Study of 131I-Caerin 1.1 and 131I-c(RGD)2 for Internal Radiation Therapy of Esophageal Cancer Xenografts.” Biomedicine & Pharmacotherapy 164 (August): 114891. doi:10.1016/j.biopha.2023.114891.